The results are in, United Therapeutics stock surges on positive drug trial results United Therapeutics Corporation (NASDAQ: UTHR) shares rose 12% Monday after the company announced its TETON-1 pivotal study of Tyvaso met its primary endpoint for treatment of...
Rocket Pharmaceuticals stock gains on FDA gene therapy approval Rocket Pharmaceuticals (NASDAQ: RCKT) shares rose 6% Friday following the U.S. Food and Drug Administration’s accelerated approval of KRESLADI, the company’s gene therapy for pediatric patients with...
Meanwhile across the pond, Soligenix receives EU orphan drug status for Behçet’s disease treatment Soligenix Inc. (NASDAQ: SNGX) announced that the European Commission granted orphan drug designation to dusquetide, the active ingredient in SGX945, for treating...
Good for the sport, BrightView (NYSE: BV) expands sports and golf operations portfolio BrightView (BV) announced expansion of its sports and golf course maintenance operations, highlighting recent projects at high-profile venues and sporting events across the United...
Feeling the love, Two Harbors Investment Corp. (NYSE: TWO) receives 2 competing acquisition proposals Two Harbors Investment Corp. (TWO) announced that its board committee has determined an unsolicited proposal from CrossCountry Mortgage constitutes a...
Feel the Rhythm, Rhythm Pharmaceuticals (NASDAQ: RYTM) stock jumps on FDA approval Rhythm Pharmaceuticals (NASDAQ: RYTM) shares rose 11% Friday morning following FDA approval of IMCIVREE (setmelanotide) for patients with acquired hypothalamic obesity.The approval...
